Cargando…
Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
BACKGROUND: Remimazolam is a new ultra short-acting benzodiazepine originally developed as an improved version of midazolam. Recent studies have demonstrated non-inferiority of remimazolam to propofol in general anesthesia. However, to date, few studies have investigated the induction bolus dose of...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Anesthesiologists
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726459/ https://www.ncbi.nlm.nih.gov/pubmed/35912426 http://dx.doi.org/10.4097/kja.22331 |